Parnassus Investments, an investment management company, released the “Parnassus Core Equity Fund” fourth quarter 2024 ...

We recently published a list of the 11 Best Pharma Stocks to Buy According to Hedge Funds. In this article, we are going to ...

Eli Lilly (LLY) closed the latest trading day ... changes in estimates have a direct relationship with upcoming stock price performance. To take advantage of this, we've established the Zacks ...

AbbVie Inc. enters the obesity market with GUBamy, a promising amylin analog. Click here to find out why ABBV stock is a Buy.

In its fourth quarter 2024 investor letter, Parnassus Core Equity Fund emphasized stocks such as Eli Lilly and Company (NYSE:LLY). Eli Lilly and Company (NYSE:LLY) is a pharmaceutical company ...

Whales with a lot of money to spend have taken a noticeably bullish stance on Eli Lilly. Looking at options history for Eli ...

So is Eli Lilly's stock worth doubling down on ... that would still have been a robust performance by industry standards. Nor is it the case that Eli Lilly relies only on its diabetes and weight ...

RiverPark Advisors, an investment advisory firm and sponsor of the RiverPark family of mutual funds, released its “RiverPark ...